Quantitative determination of atorvastatin and para-hydroxy atorvastatin in human plasma by LC-MS-MS

Journal of Chromatographic Science

Volumn 46, Issue 10, 2008, Pages 862-866

  Liu, Dongyang ^a   Jiang, Ji ^a   Zhou, Hui ^a   Hu, Pei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56549092209     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.10.862     Document Type: Article

References (12)

1. H.S. Malhotra and K.L. Goa. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. Drugs 61: 1835 (2001).
2. H. Lennernas. Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42: 1141 (2003).
3. A.S. Kearney, L.F. Crawford, S.C. Metha, and G.W. Radebaugh. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981. Pharm. Res. 10: 1461 (1993).
4. G. Bahrami, B. Mohammadia, S. Mirzaeei, and A. Kiani. Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. J. Chromatogr. B 826: 41 (2005).
5. A. Zarghi, A. Shafaati, S.M. Foroutan, and A. Khoddam. A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies. Arzneimittelforschung 55: 451 (2005).
6. V. Borek-Dohalsky, J. Huclova, B. Barrett, B. Nemec, I. Ulc, and I. Jelinek. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. Anal. Bioanal. Chem. 386: 275 (2006).
7. M. Hermann, H. Christensen, and J.L. Reubsae. Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS. Anal. Bioanal. Chem. 382: 1242 (2005).
8. W.W. Bullen, R.A. Miller, and R.N. Hayes. Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma. J. Am. Soc. Mass Spectrom. 10: 55 (1999).
9. China State food and drug administration. The Guidance of bioavailability and bioequivalence study technique for chemistry drug in human (No. [H]GCL2-1). 2005. Website: http://www.sda.gov.cn/gsz05106/08.pdf
10. M. Jemal. High-throughput quantitative bioanalysis by LC/MS/MS. Biomed. Chromatogr. 14: 422 (2000).
11. B.K. Matuszewski. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B 830: 293 (2006).
12. Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA). Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products general considerations.2003. Website: http://www.fda.gov/cder/guidance/4964dft.htm